E Fund Management Co., Ltd. Rigel Pharmaceuticals Inc Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $71,923 - $342,440	107,348 Added 614.47%	124,818 $141,000
Q1 2022 May 12, 2022	BUY	$2.22 - $3.45 $3,099 - $4,816	1,396 Added 8.68%	17,470 $52,000
Q4 2021 Feb 11, 2022	SELL	$2.36 - $3.57 $1,132 - $1,713	-480 Reduced 2.9%	16,074 $43,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $33,159 - $42,633	-9,474 Reduced 36.4%	16,554 $60,000
Q1 2021 May 12, 2021	BUY	$3.35 - $4.93 $87,193 - $128,318	26,028 New	26,028 $89,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.